Similar Items: Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literature
- CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
- A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
- Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
- Physical activity attenuates the association between allostatic load and early Alzheimer's disease‐related biomarkers in older adults
- Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
- Alzheimer's disease drug development pipeline: 2026